{
  "main_header": {
    "sid": 395126,
    "name": "Hind.Bio Science",
    "stock_name": "Hind.Bio Science",
    "full_name": "Hindustan Bio Sciences Ltd",
    "name_url": "stocks-analysis/hindbio-science",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "5.98",
    "chg": 0.28,
    "chgp": "4.91%",
    "dir": 1,
    "prev_price": "5.70",
    "mcapval": "6.13 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532041,
    "symbol": "",
    "ind_name": "Software Products",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE597C01021",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "1.54 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/hindbio-science-395126-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Hind.Bio Science falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-hindbio-science-fallingrising-3736119",
        "imagepath": "",
        "date": "2025-11-29 00:44:17",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Hindustan Bio Sciences’ stock price fell by ₹0.20, representing a 3.17% drop as of 08:35 PM on 28 November. This decline marks the continuation of a downward trend, with the stock having lost 6.58% over the past two consecutive trading days. The fall is particularly significant given that the stock has underperformed its sector by 3.72% on the same day, signalling sector-relative weakness.</p>\n<p>The stock’s performance over the short and medium term further highlights its struggles. Over the past week, the share price has declined by 8.41%, in stark contrast to the Sensex’s modest gain of 0.56%. Similarly, the one-month return shows a 6.15% loss for Hindustan Bio Sciences, while the Sensex advanced by 1.27%. These figures underscore t..."
      },
      {
        "title": "Why is Hind.Bio Science falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-hindbio-science-fallingrising-3712970",
        "imagepath": "",
        "date": "2025-11-18 22:20:36",
        "description": "As of 18-Nov, Hindustan Bio Sciences Ltd is experiencing a decline in its stock price, currently at Rs 6.59, which represents a decrease of -0.34 or -4.91%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of -9.6% during this period. Additionally, it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The stock is also close to its 52-week low, just 1.37% away from Rs 6.5. Notably, investor participation has decreased significantly, with delivery volume dropping by -75.16% compared to the 5-day average, indicating a lack of interest among investors.\n\nIn the broader market context, Hindustan Bio Sciences Ltd has underperformed relative to the benchmark Sensex, which has gained +0.96% over the past week while the stock has declined by -8.34%. Over the past month, the stock has decrease..."
      },
      {
        "title": "Is Hind.Bio Science overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-hindbio-science-overvalued-or-undervalued-3668632",
        "imagepath": "",
        "date": "2025-11-04 08:06:02",
        "description": "As of 3 November 2025, the valuation grade for Hind.Bio Science has moved from very expensive to risky. The company is currently considered overvalued. Key ratios include a PE ratio of 54.70, an EV to EBITDA of -10.08, and a PEG ratio of 0.82. \n\nIn comparison to its peers, Hind.Bio Science's PE ratio is significantly higher than Sun Pharma's 35.62 and Cipla's 22.44, indicating a premium valuation despite its negative earnings multiples. Additionally, while the stock has shown a strong return of 13.7% over the past week, it has underperformed the Sensex year-to-date, with a decline of 26.84%. Overall, these factors suggest that Hind.Bio Science is overvalued relative to its peers and financial metrics...."
      },
      {
        "title": "How has been the historical performance of Hind.Bio Science?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-hindbio-science-3662739",
        "imagepath": "",
        "date": "2025-10-31 22:39:40",
        "description": "Answer:\nThe historical performance of Hind.Bio Science shows a fluctuating trend in its financial metrics over the years.\n\nBreakdown:\nHind.Bio Science's net sales have seen a decline from 3.56 Cr in Mar'19 to 0.81 Cr in Mar'25, with a peak of 1.94 Cr in Mar'20 and a slight recovery to 1.03 Cr in Mar'24 before falling again. Total operating income followed a similar trajectory, peaking at 3.56 Cr in Mar'19 and dropping to 0.81 Cr in Mar'25. The company has consistently reported no raw material costs, while the purchase of finished goods decreased from 2.92 Cr in Mar'19 to 0.49 Cr in Mar'25. Operating profit margins have fluctuated significantly, with a negative margin of -127.27% in Mar'22 improving to 12.35% in Mar'25. Profit after tax also showed volatility, moving from 0.11 Cr in Mar'19 to a loss of -0.94 Cr in Mar'21, before recovering to 0.10 Cr in Mar'25. The total liabilities have decreased from 5.55 ..."
      },
      {
        "title": "Why is Hind.Bio Science falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-hindbio-science-fallingrising-3659657",
        "imagepath": "",
        "date": "2025-10-30 22:08:08",
        "description": "As of 30-Oct, Hindustan Bio Sciences Ltd's stock price is currently at 7.14, reflecting an increase of 0.34 or 5.0%. The stock has shown a positive trend recently, gaining for the last two days with a total return of 9.85%. However, despite this short-term gain, the stock has underperformed over longer periods, with a 1-month decline of 15.00% and a year-to-date drop of 30.07%. Additionally, the stock's delivery volume has significantly decreased by 77.33% compared to the 5-day average, indicating falling investor participation. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nBroader Market Context: In the context of the broader market, Hindustan Bio Sciences Ltd has outperformed its sector today by 5.34%. However, when comparing its short-term performance to the benchmark Sensex, the stock's 1-week return of -2.06% contrasts ..."
      },
      {
        "title": "Why is Hind.Bio Science falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-hindbio-science-fallingrising-3644817",
        "imagepath": "",
        "date": "2025-10-24 22:20:36",
        "description": "As of 24-Oct, Hindustan Bio Sciences Ltd is experiencing a decline in its stock price, currently at Rs. 6.57, which represents a decrease of 0.72 or 9.88%. The stock has hit a new 52-week low today and has underperformed its sector by 9.49%. Over the past three days, the stock has consecutively fallen, resulting in a total decline of 26.92%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In terms of performance against benchmarks, the stock has seen significant declines over various periods, including a 20.36% drop over the past week and a 35.65% decline year-to-date, while the Sensex has shown positive returns in the same periods.\n\nIn the broader market context, while the Sensex has gained 0.31% over the past week and 3.05% over the past month, Hindustan Bio Sciences Ltd has significantly lagged behind, indicating a stark contrast in performance. T..."
      },
      {
        "title": "Why is Hind.Bio Science falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-hindbio-science-fallingrising-3641611",
        "imagepath": "",
        "date": "2025-10-23 22:05:34",
        "description": "As of 23-Oct, Hindustan Bio Sciences Ltd is experiencing a decline in its stock price, currently at 7.29, reflecting a decrease of 0.81 or 10.0%. The stock has underperformed significantly, with a consecutive fall over the last two days resulting in a total return drop of 18.91%. Additionally, it is trading below all its moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), indicating a bearish trend. The delivery volume has also decreased sharply by 65.19% compared to the 5-day average, suggesting reduced investor participation. Unfortunately, there is no information available regarding positive or negative factors impacting the stock.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has gained 1.30% over the past week, Hindustan Bio Sciences Ltd has seen a significant decline of 10.66% during the same period. This stark contrast highlights the stock's underperformance relativ..."
      },
      {
        "title": "Why is Hind.Bio Science falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-hindbio-science-fallingrising-3635742",
        "imagepath": "",
        "date": "2025-10-20 21:50:20",
        "description": "As of 20-Oct, Hindustan Bio Sciences Ltd is experiencing a rise in its stock price, currently at 8.99, which reflects an increase of 0.74 or 8.97%. The stock has shown strong performance recently, gaining 10.17% over the last two days and outperforming its sector by 8.29% today. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The delivery volume has also seen a significant increase, rising by 139.81% against the 5-day average, suggesting heightened investor interest. Unfortunately, there is no information available regarding any positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Hindustan Bio Sciences Ltd has outperformed the Sensex in the short term, with a 1-week return of 12.80% compared to the Sensex's 2.47%. This trend of outperformance is consistent over the..."
      },
      {
        "title": "When is the next results date for Hind.Bio Science?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-hindbio-science-3630184",
        "imagepath": "",
        "date": "2025-10-17 23:15:42",
        "description": "Hind.Bio Science will declare its results on 31 October 2025...."
      }
    ],
    "total": 93,
    "sid": "395126",
    "stock_news_url": "https://www.marketsmojo.com/news/hindustan-bio-sciences-395126"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "03-Nov-2025",
      "details": "Newspaper Publication of Un-audited financial results for the half year and quarter ended 30th September 2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On 31-10-2025",
      "datetime": "31-Oct-2025",
      "details": "Outcome of board meeting held on 31-10-2025",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Consider The Unaudited Standalone Financial Results Of The Company For The Second Quarter And Half Year Ended On September 30 2025 Along With Limited Review Report",
      "datetime": "16-Oct-2025",
      "details": "Hindustan Bio Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2025 inter alia to consider and approve Unaudited Standalone Financial Results for the Second quarter and half year ended on September 30 2025 along with Limited Review Report",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Hind.Bio Science falling/rising?

2025-11-29 00:44:17

Recent Price Movement and Market Context

Hindustan Bio Sciences’ stock price fell by ₹0.20, representing a 3.17% drop as of 08:35 PM on 28 November. This decline marks the continuation of a downward trend, with the stock having lost 6.58% over the past two consecutive trading days. The fall is particularly significant given that the stock has underperformed its sector by 3.72% on the same day, signalling sector-relative weakness.

The stock’s performance over the short and medium term further highlights its struggles. Over the past week, the share price has declined by 8.41%, in stark contrast to the Sensex’s modest gain of 0.56%. Similarly, the one-month return shows a 6.15% loss for Hindustan Bio Sciences, while the Sensex advanced by 1.27%. These figures underscore t...

Read More

Why is Hind.Bio Science falling/rising?

2025-11-18 22:20:36

As of 18-Nov, Hindustan Bio Sciences Ltd is experiencing a decline in its stock price, currently at Rs 6.59, which represents a decrease of -0.34 or -4.91%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of -9.6% during this period. Additionally, it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The stock is also close to its 52-week low, just 1.37% away from Rs 6.5. Notably, investor participation has decreased significantly, with delivery volume dropping by -75.16% compared to the 5-day average, indicating a lack of interest among investors. In the broader market context, Hindustan Bio Sciences Ltd has underperformed relative to the benchmark Sensex, which has gained +0.96% over the past week while the stock has declined by -8.34%. Over the past month, the stock has decrease...

Read More

Is Hind.Bio Science overvalued or undervalued?

2025-11-04 08:06:02

As of 3 November 2025, the valuation grade for Hind.Bio Science has moved from very expensive to risky. The company is currently considered overvalued. Key ratios include a PE ratio of 54.70, an EV to EBITDA of -10.08, and a PEG ratio of 0.82. In comparison to its peers, Hind.Bio Science's PE ratio is significantly higher than Sun Pharma's 35.62 and Cipla's 22.44, indicating a premium valuation despite its negative earnings multiples. Additionally, while the stock has shown a strong return of 13.7% over the past week, it has underperformed the Sensex year-to-date, with a decline of 26.84%. Overall, these factors suggest that Hind.Bio Science is overvalued relative to its peers and financial metrics....

Read More

How has been the historical performance of Hind.Bio Science?

2025-10-31 22:39:40

Answer: The historical performance of Hind.Bio Science shows a fluctuating trend in its financial metrics over the years. Breakdown: Hind.Bio Science's net sales have seen a decline from 3.56 Cr in Mar'19 to 0.81 Cr in Mar'25, with a peak of 1.94 Cr in Mar'20 and a slight recovery to 1.03 Cr in Mar'24 before falling again. Total operating income followed a similar trajectory, peaking at 3.56 Cr in Mar'19 and dropping to 0.81 Cr in Mar'25. The company has consistently reported no raw material costs, while the purchase of finished goods decreased from 2.92 Cr in Mar'19 to 0.49 Cr in Mar'25. Operating profit margins have fluctuated significantly, with a negative margin of -127.27% in Mar'22 improving to 12.35% in Mar'25. Profit after tax also showed volatility, moving from 0.11 Cr in Mar'19 to a loss of -0.94 Cr in Mar'21, before recovering to 0.10 Cr in Mar'25. The total liabilities have decreased from 5.55 ...

Read More

Why is Hind.Bio Science falling/rising?

2025-10-30 22:08:08

As of 30-Oct, Hindustan Bio Sciences Ltd's stock price is currently at 7.14, reflecting an increase of 0.34 or 5.0%. The stock has shown a positive trend recently, gaining for the last two days with a total return of 9.85%. However, despite this short-term gain, the stock has underperformed over longer periods, with a 1-month decline of 15.00% and a year-to-date drop of 30.07%. Additionally, the stock's delivery volume has significantly decreased by 77.33% compared to the 5-day average, indicating falling investor participation. There is no information available regarding positive or negative factors that could further explain the stock's recent movement. Broader Market Context: In the context of the broader market, Hindustan Bio Sciences Ltd has outperformed its sector today by 5.34%. However, when comparing its short-term performance to the benchmark Sensex, the stock's 1-week return of -2.06% contrasts ...

Read More

Why is Hind.Bio Science falling/rising?

2025-10-24 22:20:36

As of 24-Oct, Hindustan Bio Sciences Ltd is experiencing a decline in its stock price, currently at Rs. 6.57, which represents a decrease of 0.72 or 9.88%. The stock has hit a new 52-week low today and has underperformed its sector by 9.49%. Over the past three days, the stock has consecutively fallen, resulting in a total decline of 26.92%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. In terms of performance against benchmarks, the stock has seen significant declines over various periods, including a 20.36% drop over the past week and a 35.65% decline year-to-date, while the Sensex has shown positive returns in the same periods. In the broader market context, while the Sensex has gained 0.31% over the past week and 3.05% over the past month, Hindustan Bio Sciences Ltd has significantly lagged behind, indicating a stark contrast in performance. T...

Read More

Why is Hind.Bio Science falling/rising?

2025-10-23 22:05:34

As of 23-Oct, Hindustan Bio Sciences Ltd is experiencing a decline in its stock price, currently at 7.29, reflecting a decrease of 0.81 or 10.0%. The stock has underperformed significantly, with a consecutive fall over the last two days resulting in a total return drop of 18.91%. Additionally, it is trading below all its moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), indicating a bearish trend. The delivery volume has also decreased sharply by 65.19% compared to the 5-day average, suggesting reduced investor participation. Unfortunately, there is no information available regarding positive or negative factors impacting the stock. Broader Market Context: In comparison to the benchmark Sensex, which has gained 1.30% over the past week, Hindustan Bio Sciences Ltd has seen a significant decline of 10.66% during the same period. This stark contrast highlights the stock's underperformance relativ...

Read More

Why is Hind.Bio Science falling/rising?

2025-10-20 21:50:20

As of 20-Oct, Hindustan Bio Sciences Ltd is experiencing a rise in its stock price, currently at 8.99, which reflects an increase of 0.74 or 8.97%. The stock has shown strong performance recently, gaining 10.17% over the last two days and outperforming its sector by 8.29% today. Additionally, it is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. The delivery volume has also seen a significant increase, rising by 139.81% against the 5-day average, suggesting heightened investor interest. Unfortunately, there is no information available regarding any positive or negative factors that could further explain the stock's recent movement. In the broader market context, Hindustan Bio Sciences Ltd has outperformed the Sensex in the short term, with a 1-week return of 12.80% compared to the Sensex's 2.47%. This trend of outperformance is consistent over the...

Read More

When is the next results date for Hind.Bio Science?

2025-10-17 23:15:42

Hind.Bio Science will declare its results on 31 October 2025....

Read More

View All News